Cover Image

A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Yu Du, Jianghao Li, Sohini Raha, Yongming Qu
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Statistics in Medicine
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Doubly adaptive biased coin design to improve Bayesian clinical trials with time‐to‐event endpoints
by: Wenhao Cao, et al.
Published: (2024)

Correction to “Using principal stratification in analysis of clinical trials”
by: Ilya Lipkovich, et al.
Published: (2024)

Correction to “Propensity score weighting for covariate adjustment in randomized clinical trials”
by: Shuxi Zeng, et al.
Published: (2024)

A class of computational methods to reduce selection bias when designing Phase 3 clinical trials
by: Tianyu Zhan
Published: (2024)

Covariate‐adjusted generalized pairwise comparisons in small samples
by: Stijn Jaspers, et al.
Published: (2024)

Are the tests overpowered or underpowered? A unified solution to correctly specify type I errors in design of clinical trials for two sample proportions
by: Peiran Liu, et al.
Published: (2024)

Two‐stage randomized clinical trials with a right‐censored endpoint: Comparison of frequentist and Bayesian adaptive designs
by: Luana Boumendil, et al.
Published: (2024)

A comparison of hyperparameter tuning procedures for clinical prediction models: A simulation study
by: Zoë S. Dunias, et al.
Published: (2024)

Use of win time for ordered composite endpoints in clinical trials
by: James F. Troendle, et al.
Published: (2024)

Improved mortality analysis in early‐phase dose‐ranging clinical trials for emergency medical diseases using Bayesian time‐to‐event models with active comparators
by: Xiaosong Shi, et al.
Published: (2024)

A sequential, multiple assignment, randomized trial design with a tailoring function
by: Holly Hartman, et al.
Published: (2024)

Confidence distributions for treatment effects in clinical trials: Posteriors without priors
by: Ian C. Marschner
Published: (2024)

Design and sample size determination for multiple‐dose randomized phase II trials for dose optimization
by: Peng Yang, et al.
Published: (2024)

Group sequential designs for clinical trials when the maximum sample size is uncertain
by: Amin Yarahmadi, et al.
Published: (2024)

Assurance methods for designing a clinical trial with a delayed treatment effect
by: James A. Salsbury, et al.
Published: (2024)

Comparison of methods that combine multiple randomized trials to estimate heterogeneous treatment effects
by: Carly Lupton Brantner, et al.
Published: (2024)

Likelihood ratio combination of multiple biomarkers via smoothing spline estimated densities
by: Zhiyuan Du, et al.
Published: (2024)

Dual‐agent dose‐finding in Phase I clinical trial—An extension of rapid enrollment design
by: Yunfei Wang
Published: (2024)

Dynamic path analysis for exploring treatment effect mediation processes in clinical trials with time‐to‐event endpoints
by: Matthias Kormaksson, et al.
Published: (2024)

A Bayesian framework for modeling COVID‐19 case numbers through longitudinal monitoring of SARS‐CoV‐2 RNA in wastewater
by: Xiaotian Dai, et al.
Published: (2024)

Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi‐center clinical trial
by: Johannes Krisam, et al.
Published: (2024)

Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two‐by‐two table
by: Edward L. Korn, et al.
Published: (2024)

Fractional accumulative calibration‐free odds (f‐aCFO) design for delayed toxicity in phase I clinical trials
by: Jialu Fang, et al.
Published: (2024)

Categorisation of continuous covariates for stratified randomisation: How should we adjust?
by: Thomas R. Sullivan, et al.
Published: (2024)

Bayesian Tensor Decomposition for Clustering Latent Symptom Profiles for Verbal Autopsy Data
by: Yu Zhu, et al.
Published: (2026)

Two‐stage stratified designs with survival outcomes and adjustment for misclassification in predictive biomarkers
by: Yanping Chen, et al.
Published: (2024)

Beyond the two‐trials rule
by: Leonhard Held
Published: (2024)

Bayesian Empirical Likelihood Regression for Semiparametric Estimation of Optimal Dynamic Treatment Regimes
by: Weichang Yu, et al.
Published: (2024)

Multiply robust generalized estimating equations for cluster randomized trials with missing outcomes
by: Dustin J. Rabideau, et al.
Published: (2024)

A Bayesian Approach to the G‐Formula via Iterative Conditional Regression
by: Ruyi Liu, et al.
Published: (2025)

A Generalized Bayesian Stochastic Block Model for Microbiome Community Detection
by: Kevin C. Lutz, et al.
Published: (2025)

Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs
by: Jonathan C. Moyer, et al.
Published: (2024)

Confidence intervals for odds ratio from multistage randomized phase II trials
by: Shiwei Cao, et al.
Published: (2024)

Modeling multiple‐criterion diagnoses by heterogeneous‐instance logistic regression
by: Chun‐Hao Yang, et al.
Published: (2024)

A Bayesian Approach for Robust Longitudinal Envelope Models
by: Peng Zeng, et al.
Published: (2026)

Estimation and reduction of bias in self‐controlled case series with non‐rare event dependent outcomes and heterogeneous populations
by: Kenneth Menglin Lee, et al.
Published: (2024)

Bayesian survival analysis with INLA
by: Danilo Alvares, et al.
Published: (2024)

Bayesian Longitudinal Network Regression With Application to Brain Connectome Genetics
by: Chenxi Li, et al.
Published: (2025)

Bayesian Modeling of Cancer Outcomes Using Genetic Variables Assisted by Pathological Imaging Data
by: Yunju Im, et al.
Published: (2025)

A modeling framework for the analysis of the SARS‐CoV2 transmission dynamics
by: Anastasia Chatzilena, et al.
Published: (2024)